Cargando…
Small Molecule Drugs Targeting Non-Coding RNAs as Treatments for Alzheimer’s Disease and Related Dementias
Despite the enormous burden of Alzheimer’s disease and related dementias (ADRD) on patients, caregivers, and society, only a few treatments with limited efficacy are currently available. While drug development conventionally focuses on disease-associated proteins, RNA has recently been shown to be d...
Autores principales: | Nguyen, Lien D., Chau, Rachel K., Krichevsky, Anna M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701955/ https://www.ncbi.nlm.nih.gov/pubmed/34946953 http://dx.doi.org/10.3390/genes12122005 |
Ejemplares similares
-
Small Molecule Regulators of microRNAs Identified by High-Throughput Screen Coupled with High-Throughput Sequencing
por: Krichevsky, Anna, et al.
Publicado: (2023) -
Dissecting the role of non-coding RNAs in the accumulation of amyloid and tau neuropathologies in Alzheimer’s disease
por: Patrick, Ellis, et al.
Publicado: (2017) -
Non-Coding RNAs and Oral Cancer: Small Molecules With Big Functions
por: Erfanparast, Leila, et al.
Publicado: (2022) -
Small molecule regulators of microRNAs identified by high-throughput screen coupled with high-throughput sequencing
por: Nguyen, Lien D., et al.
Publicado: (2023) -
Oligonucleotide Therapeutics as a New Class of Drugs for Malignant Brain Tumors: Targeting mRNAs, Regulatory RNAs, Mutations, Combinations, and Beyond
por: Krichevsky, Anna M., et al.
Publicado: (2019)